radiopharmaceutical production quality control testing visual inspection stop
TRANSCRIPT
![Page 1: Radiopharmaceutical Production Quality Control Testing Visual Inspection STOP](https://reader036.vdocuments.mx/reader036/viewer/2022082611/56649e155503460f94afeaaa/html5/thumbnails/1.jpg)
Radiopharmaceutical Production
Quality Control Testing
Visual Inspection
STOP
![Page 2: Radiopharmaceutical Production Quality Control Testing Visual Inspection STOP](https://reader036.vdocuments.mx/reader036/viewer/2022082611/56649e155503460f94afeaaa/html5/thumbnails/2.jpg)
Visual Inspection
• The radiopharmaceutical should be inspected visually to check for the color and presence of any particulate matter.
Contents• Acceptance Criteria• Discussion• Procedure
STOP
![Page 3: Radiopharmaceutical Production Quality Control Testing Visual Inspection STOP](https://reader036.vdocuments.mx/reader036/viewer/2022082611/56649e155503460f94afeaaa/html5/thumbnails/3.jpg)
Radiopharmaceutical Production
QC Testing
Visual Inspection
Contents
Acceptance Criteria
Discussion
Procedure
STOP
Acceptance CriteriaAcceptance Criteria: The product should be clear, colorless and
free from particulate matter. The test should be completed on every batch prior to release of product.
Procedure: Hold the test sample in the path of a strong light beam and against a white and a black background to inspect colour and presence of particulate matter. For sake of radiation protection, the vial content is viewed through a leaded glass. Non-tinted glass or indirect viewing using a mirror or video camera is preferred to eliminate the possibility of false observation of colour in the solution.
![Page 4: Radiopharmaceutical Production Quality Control Testing Visual Inspection STOP](https://reader036.vdocuments.mx/reader036/viewer/2022082611/56649e155503460f94afeaaa/html5/thumbnails/4.jpg)
Radiopharmaceutical Production
QC Testing
Visual Inspection
Contents
Acceptance Criteria
Discussion
Procedure
STOP
DiscussionDiscussion: A slight yellow color in the preparation is acceptable
according to IP and Ph. Eur. specifications due to the fact that the sample is often viewed through tinted glass. However, experience shows that FDG preparations are generally colorless. Therefore, ‘slightly yellow’ color in the product should be treated with caution as this occurrence indicates the likely presence of impurities arising during manufacturing.
Visual inspection is a measure of the process performance. Presence of particulate matter in the product indicates possible failure at various stages of manufacturing including:
• failure of the sterilizing filtration, • inadequate cleaning and control of glassware and components, • inadequate environmental control during assembly of reagents
in pre-installation stage, and perhaps • operator error.
![Page 5: Radiopharmaceutical Production Quality Control Testing Visual Inspection STOP](https://reader036.vdocuments.mx/reader036/viewer/2022082611/56649e155503460f94afeaaa/html5/thumbnails/5.jpg)
Radiopharmaceutical Production
QC Testing
Visual Inspection
Contents
Acceptance Criteria
Discussion
Procedure
STOP
ProcedureNote: A closer visual inspection may be performed on the reserve
sample several half-lives post-production.
Procedure: Hold the test sample in the path of a strong light beam and against a white and a black background to inspect colour and presence of particulate matter. For sake of radiation protection, the vial content is viewed through a leaded glass. Non-tinted glass or indirect viewing using a mirror or video camera is preferred to eliminate the possibility of false observation of colour in the solution.
Link to demonstration
![Page 6: Radiopharmaceutical Production Quality Control Testing Visual Inspection STOP](https://reader036.vdocuments.mx/reader036/viewer/2022082611/56649e155503460f94afeaaa/html5/thumbnails/6.jpg)
Return to Main Menu